TY - JOUR
T1 - Interventions to prevent repeat suicidal behavior in patients admitted to an emergency department for a suicide attempt
T2 - A meta-analysis
AU - Inagaki, Masatoshi
AU - Kawashima, Yoshitaka
AU - Kawanishi, Chiaki
AU - Yonemoto, Naohiro
AU - Sugimoto, Tatsuya
AU - Furuno, Taku
AU - Ikeshita, Katsumi
AU - Eto, Nobuaki
AU - Tachikawa, Hirokazu
AU - Shiraishi, Yohko
AU - Yamada, Mitsuhiko
N1 - Funding Information:
This study was supported in part by a grant for Research on Psychiatric and Neurological Disease and Mental Health from the Ministry of Health, Labor and Welfare (MHLW). The MHLW had no role in study design, data collection, analysis, interpretation of the results, or writing of the report, and had no influence over submission of the manuscript.
Funding Information:
Dr. Inagaki reports grants from the Ministry of Health, Labour and Welfare, personal fees from Pfizer Japan Inc., personal fees from Mochida Pharmaceutical Co., Ltd., personal fees from Nippon Hyoron Sha Co., Ltd., personal fees from Nanzando Co., Ltd., personal fees from Seiwa Shoten Co., Ltd., personal fees from Igaku-shoin Ltd., and personal fees from Technomics, Inc., outside the submitted work. Dr. Kawanishi reports grants from The Ministory of Health, Labour and Welfare, Japan, grants from The Ministory of Education, Culture, Sports, Science and Technology, Japan, grants from The Japan Science and Tecnhology Agency, personal fees from Meiji Seika Pharma Co., Ltd., personal fees from GlaxoSmithKline K.K., and personal fees from Pfizer K.K., outside the submitted work. Dr. Ikeshita reports personal fees from Mochida Pharmaceutical Co., Ltd., outside the submitted work. Dr. Yamada reports grants from The Ministry of Health, Labour and Welfare, Japan, during the conduct of the study; grants from The Ministry of Education, Culture, Sports, Science and Technology, Japan, grants from The Japan Science and Technology Agency, grants from National Center of Neurology and Psychiatry, personal fees from Meiji Seika Pharma Co., Ltd., personal fees from MSD K.K., personal fees from Asahi Kasei Pharma Corporation, personal fees from Seishin Shobo, personal fees from Seiwa Shoten Co., Ltd., personal fees from Igaku-shoin Ltd., personal fees from Chogai Igakusha, and personal fees from Sentan Igakusha, outside the submitted work. No other authors report potential conflict of interest.
Publisher Copyright:
© 2014 Elsevier B.V. All rights reserved.
PY - 2015/4/1
Y1 - 2015/4/1
N2 - Background: A huge number of patients with self-harm and suicide attempt visit emergency departments (EDs). We systematically reviewed studies and examined the effect of interventions to prevent repeat suicidal behavior in patients admitted to EDs for a suicidal attempt. Method: We searched the databases of MEDLINE, PsychoINFO, CINAHL, and EMBASE through August 2013. Eligible studies were randomized controlled trials assessing the effects on repeat suicidal behavior of interventions initiated in suicidal patients admitted to EDs. Interventions in each trial were classified into groups by consensus. Meta-analyses were performed to determine pooled relative risks (RRs) and 95% confidence intervals (CIs) of repetition of suicide attempt for interventions in each group. Results: Out of 5390 retrieved articles, 24 trials were included and classified into four groups (11 trials in the Active contact and follow-up, nine in the Psychotherapy, one in the Pharmacotherapy, and three in the Miscellaneous). Active contact and follow-up type interventions were effective in preventing a repeat suicide within 12 months (n = 5319; pooled RR = 0.83; 95% CI: 0.71 to 0.97). However, the effect at 24 months was not confirmed (n = 925; pooled RR = 0.98; 95% CI: 0.76-1.22). The effects of the other interventions on preventing a repetition of suicidal behavior remain unclear. Limitation: Caution is needed regarding the heterogeneity of the effects. Conclusion: Interventions of active contact and follow-up are recommended to reduce the risk of a repeat suicide attempt at 12 months in patients admitted to EDs with a suicide attempt. However, the long-term effect was not confirmed.
AB - Background: A huge number of patients with self-harm and suicide attempt visit emergency departments (EDs). We systematically reviewed studies and examined the effect of interventions to prevent repeat suicidal behavior in patients admitted to EDs for a suicidal attempt. Method: We searched the databases of MEDLINE, PsychoINFO, CINAHL, and EMBASE through August 2013. Eligible studies were randomized controlled trials assessing the effects on repeat suicidal behavior of interventions initiated in suicidal patients admitted to EDs. Interventions in each trial were classified into groups by consensus. Meta-analyses were performed to determine pooled relative risks (RRs) and 95% confidence intervals (CIs) of repetition of suicide attempt for interventions in each group. Results: Out of 5390 retrieved articles, 24 trials were included and classified into four groups (11 trials in the Active contact and follow-up, nine in the Psychotherapy, one in the Pharmacotherapy, and three in the Miscellaneous). Active contact and follow-up type interventions were effective in preventing a repeat suicide within 12 months (n = 5319; pooled RR = 0.83; 95% CI: 0.71 to 0.97). However, the effect at 24 months was not confirmed (n = 925; pooled RR = 0.98; 95% CI: 0.76-1.22). The effects of the other interventions on preventing a repetition of suicidal behavior remain unclear. Limitation: Caution is needed regarding the heterogeneity of the effects. Conclusion: Interventions of active contact and follow-up are recommended to reduce the risk of a repeat suicide attempt at 12 months in patients admitted to EDs with a suicide attempt. However, the long-term effect was not confirmed.
KW - Emergency department
KW - Meta-analysis
KW - Self-harm
KW - Suicide
KW - Systematic review
UR - http://www.scopus.com/inward/record.url?scp=84921791095&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84921791095&partnerID=8YFLogxK
U2 - 10.1016/j.jad.2014.12.048
DO - 10.1016/j.jad.2014.12.048
M3 - Review article
C2 - 25594513
AN - SCOPUS:84921791095
SN - 0165-0327
VL - 175
SP - 66
EP - 78
JO - Journal of Affective Disorders
JF - Journal of Affective Disorders
ER -